Publication: Long-term prognostic value of elevated pentraxin 3 in patients undergoing primary angioplasty for ST-elevation myocardial infarction
Loading...
Program
relationships.isAuthorOf
Author
Akgul, Ozgur
Baycan, Omer Faruk
Bulut, Umit
Somuncu, Mustafa Umut
Pusuroglu, Hamdi
Ozyilmaz, Sinem
Gul, Mehmet
Demir, Ali Riza
Yilmaz, Emre
Yazan, Serkan
Advisor
Language
Type
Publisher
Journal Title
Journal ISSN
Volume Title
Abstract
Objectives The prognostic value of pentraxin 3 (PTX3) has been documented in patients with acute coronary syndrome. However, its long-term prognostic value in acute ST-segment elevation myocardial infarction (STEMI) remains unclear. The aim of this study was to evaluate the prognostic value of PTX3 in patients with STEMI undergoing a primary percutaneous coronary intervention (PCI).
Description
Source
Keywords
Keywords
Citation
Akgul O., Baycan O. F. , Bulut U., Somuncu M. U. , Pusuroglu H., Ozyilmaz S., Gul M., Demir A. R. , Yilmaz E., Yazan S., et al., -Long-term prognostic value of elevated pentraxin 3 in patients undergoing primary angioplasty for ST-elevation myocardial infarction-, CORONARY ARTERY DISEASE, cilt.26, ss.592-597, 2015